Page last updated: 2024-11-09

capsazepine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

capsazepine: modified capsaicin molecule; a capsaicin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

capsazepine : A benzazepine that is 2,3,4,5-tetrahydro-1H-2-benzazepine which is substituted by hydroxy groups at positions 7 and 8 and on the nitrogen atom by a 2-(p-chlorophenyl)ethylaminothiocarbonyl group. A synthetic analogue of capsaicin, it was the first reported capsaicin receptor antagonist. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2733484
CHEMBL ID391997
CHEBI ID70773
SCHEMBL ID122421
MeSH IDM0194001

Synonyms (102)

Synonym
MLS002153524
smr001230854
HMS3266C14
BRD-K44849676-001-03-0
gtpl2461
EU-0100373
capsazepine, >=98% (hplc), solid
tocris-0464
BIO1_000394
BIO1_001372
NCGC00024602-01
BIO2_000750
NCGC00015190-01
BIO2_000270
BIO1_000883
lopac-c-191
LOPAC0_000373
BSPBIO_001550
bdbm20284
chembl391997 ,
n-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-2,3,4,5-tetrahydro-1h-2-benzazepine-2-carbothioamide
n-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide
capsazepine
n-[2-(4-chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2h-2-benzazepine-2-carbothioamide
NCGC00024602-04
KBIO2_000270
KBIO3_000540
KBIOSS_000270
KBIO2_005406
KBIOGR_000270
KBIO2_002838
KBIO3_000539
IDI1_034020
NCGC00024602-02
NCGC00024602-03
NCGC00015190-03
n-[2-(4-chlorophenyl)ethyl]-1,3,4,5-tetrahydro-
7,8-dihydroxy-2h-2-benzazepine-2-carbothioamide
C-191
HMS1989N12
NCGC00015190-07
chebi:70773 ,
138977-28-3
HMS1791N12
HMS1361N12
ST50826300 ,
FT-0664232
unii-lfw48my844
lfw48my844 ,
HMS3261K07
CCG-204468
HMS2230F13
NCGC00015190-06
NCGC00015190-02
NCGC00015190-04
NCGC00015190-05
LP00373
capsazepin
n-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2h-2-benzazepine-2-carbothioamide
n-(2-[4-chlorophenyl]ethyl)-1,3,4,5-tetrahydro-7,8-dihydroxy-2h-2-benzazepine-2-carbothioamide
2-[2-(4-chlorophenyl)ethylamino-thiocarbonyl]-7,8-dihydroxy-2,3,4,5-tetrahydro-1h-2-benzazepine
n-(2-(4-chlorophenyl)ethyl)-1,3,4,5-tetrahydro-7,8-dihydroxy-2h-2-benzazepine-2-carbothioamide
S8137
HMS3372M06
NK101
CS-1572
HY-15640
SCHEMBL122421
tox21_500373
NCGC00261058-01
DRCMAZOSEIMCHM-UHFFFAOYSA-N
HB1040
6et ,
AKOS024458271
HMS3402N12
c19h21cln2o2s
HMS3650G17
mfcd00153778
DTXSID20160852
AS-74621
capasazepine
J-007205
SR-01000075437-3
sr-01000075437
SR-01000075437-1
Q5036336
capsazepine - cas 138977-28-3
HMS3675O03
n-(4-chlorophenethyl)-7,8-dihydroxy-4,5-dihydro-1h-benzo[c]azepine-2(3h)-carbothioamide
SR-01000075437-7
BCP12782
HMS3411O03
SDCCGSBI-0050361.P002
2h-2-benzazepine-2-carbothioamide, n-[2-(4-chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-
NCGC00015190-14
HMS3886D06
HMS3748G07
C-120
n-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide.
A857043
2-[[2-(4-chlorophenyl)ethylamino]thiocarbonyl]-2,3,4,5-tetrahydro-1h-2-benzazepine-7,8-diol
EX-A7842E

Research Excerpts

Overview

Capsazepine is an antagonist of the transient receptor potential channel vanilloid 1 (TRPV1), which is known to play an important role in the regulation of pain and inflammation. It is a synthetic analogue of the sensory neurone excitotoxin, capsaicin.

ExcerptReferenceRelevance
"Capsazepine is an antagonist of the transient receptor potential channel vanilloid 1 (TRPV1), which is known to play an important role in the regulation of pain and inflammation. "( Characterization of in vitro metabolism of capsazepine, a vanilloid transient receptor potential channel antagonist, by liquid chromatography quadrupole ion trap mass spectrometry.
Beaudry, F; Douat, J; Vachon, P, 2011
)
2.07
"Capsazepine (CPZ, 1) is a well-known vanilloid receptor (VR1) antagonist that has been cited widely used in the literature. "( An efficient parallel synthesis of capsazepine and capsazepine analogs.
Kyle, DJ; Tafesse, L, 2004
)
2.04
"Capsazepine is thought to be a selective antagonist of vanilloid type 1 receptors; however, its other in vitro effect on different cell types is unclear. "( Capsazepine elevates intracellular Ca2+ in human osteosarcoma cells, questioning its selectivity as a vanilloid receptor antagonist.
Chang, HT; Chen, JS; Cheng, HH; Cheng, JS; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Jiann, BP; Lo, YK; Teng, HP; Yeh, JH, 2004
)
3.21
"1. Capsazepine is a synthetic analogue of the sensory neurone excitotoxin, capsaicin. "( Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.
Bevan, S; Hothi, S; Hughes, G; James, IF; Rang, HP; Shah, K; Walpole, CS; Yeats, JC, 1992
)
2.35

Effects

Capsazepine has been widely used as a selective antagonist of vanilloid type 1 receptors; however, its other in vitro effect on most cell types is unknown. It is of interest because it relaxes human small airways.

ExcerptReferenceRelevance
"Capsazepine has multiple effects and is of interest because it relaxes human small airways."( dsRNA-induced expression of thymic stromal lymphopoietin (TSLP) in asthmatic epithelial cells is inhibited by a small airway relaxant.
Andersson, M; Bjermer, L; Brandelius, A; Calvén, J; Persson, C; Uller, L; Yudina, Y, 2011
)
1.09
"Capsazepine has been widely used as a selective antagonist of vanilloid type 1 receptors; however, its other in vitro effect on most cell types is unknown. "( Effect of capsazepine on cytosolic Ca(2+) levels and proliferation of human prostate cancer cells.
Chang, HT; Chen, WC; Cheng, HH; Chiang, AJ; Chou, CT; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Kuo, CC; Liu, SI; Lu, YC; Tseng, LL, 2006
)
2.18
"1. Capsazepine has recently been described as a competitive capsaicin antagonist. "( Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception.
Dickenson, AH; Dray, A, 1991
)
1.18

Actions

ExcerptReferenceRelevance
"Capsazepine did not inhibit the dilation brought about by either electrical stimulation or CGRP injection, while it was able to inhibit the dilation brought about by capsaicin (t5=3.4, P<0.05)."( Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
Akerman, S; Goadsby, PJ; Kaube, H, 2003
)
1.04

Treatment

Capsazepine or co-treatment with baicalein attenuated translocation of PKCα, PKCδ and PKCε. Treatment did not affect parasitaemia.

ExcerptReferenceRelevance
"Capsazepine-treated mice demonstrated decreased brain edema (p = 0.010), Evans Blue extravasation (p = 0.001), tissue hemoglobin levels (p = 0.002), and loss of tight junction proteins (p = 0.016 ZO-1 expression; p = 0.013 occludin expression) after TBI compared with the vehicle-treated group."( Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice.
Geng, Z; Jing, Y; Liu, YL; Tian, HL; Wang, ML; Xu, ZM; Yang, DX; Yuan, F, 2019
)
1.24
"Capsazepine or co-treatment with baicalein attenuated translocation of PKCα, PKCδ and PKCε, but not that of PKCζ."( Hypoxic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway.
Chen, YS; Huang, HS; Lu, MJ; Ma, MC, 2014
)
1.12
"Capsazepine treatment did not affect parasitaemia."( TRPV1 antagonism by capsazepine modulates innate immune response in mice infected with Plasmodium berghei ANKA.
Azevedo-Santos, AP; Barboza, R; Brain, SD; Brito, CX; Costa, SK; dos Reis, AS; Fernandes, ES; Grisotto, MA; Marinho, CR; Muscará, M; Teixeira, SA, 2014
)
1.45
"Capsazepine treatment attenuates significantly systemic inflammation and multiple organ damage caused by sepsis, and protects against sepsis-induced mortality. "( Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis.
Ang, SF; Bhatia, M; Moochhala, SM, 2010
)
1.8
"Capsazepine pretreatment significantly reduced all inflammatory parameters in LTB4-induced pancreatitis."( Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats.
Liddle, RA; McVey, DC; Nathan, JD; Shahid, RA; Vigna, SR, 2011
)
1.09
"Capsazepine treatment protected the parenchymal blood-brain barrier by limiting the post-ischemic permeability increase to about one third, but had no effect on the pia or radial vessel permeability."( Novel technique for estimating cerebrovascular permeability demonstrates capsazepine protection following ischemia-reperfusion.
Fraser, PA; Gauden, V; Hu, DE; Kurokawa, T; Sarker, MH,
)
1.08
"Capsazepine treatment significantly reduced the level of NK1R endocytosis, and this was associated with similar reductions in pancreatic MPO activity and histological severity of pancreatitis."( Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis.
Liddle, RA; McVey, DC; Nathan, JD; Patel, AA; Prpic, V; Thomas, JE; Vigna, SR, 2001
)
1.03
"Mice treated with capsazepine at the time of SΦ874 infection failed to develop chronic allodynia, whereas capsazepine treatment of mice at two weeks following SΦ874 infection did not reduce chronic allodynia."( TRPV1 and the MCP-1/CCR2 Axis Modulate Post-UTI Chronic Pain.
Klumpp, DJ; Miller, RJ; Rosen, JM; Schaeffer, AJ; Woida, PJ; Yaggie, RE, 2018
)
0.8
"pretreatment with capsazepine, ondansetron or HC030031."( Linalool-rich rosewood oil induces vago-vagal bradycardic and depressor reflex in rats.
Correia Junior, CA; da Cunha, PJ; da Silva, MT; de Siqueira, RJ; dos Santos, AA; Duarte, GP; Lahlou, S; Magalhães, PJ; Maia, JG; Rodrigues, KM, 2014
)
0.73
"Pretreatment with capsazepine, vanilloid receptor 1 (VR1) antagonist, antagonized all the three parameters of cardiorespiratory responses evoked by venom."( Nociceptive vascular reflexes evoked by scorpion venom modulate cardiorespiratory parameters involving vanilloid receptor 1 in anaesthetised rats.
Deshpande, SB; Singh, SK, 2009
)
0.68
"Pretreatment with capsazepine, CGRP(8-37), indomethacin, and denervation of primary sensory nerves significantly increased blood urea nitrogen and serum creatinine levels, renal vascular permeability, renal tissue levels of myeloperoxidase activity, cytokine-induced neutrophil chemoattractant, and tumor necrosis factor-alpha, and decreased renal tissue blood flow."( Activation of sensory neurons reduces ischemia/reperfusion-induced acute renal injury in rats.
Kadoi, Y; Kudo, K; Mizutani, A; Mizutani, S; Murakami, K; Noguchi, T; Okajima, K; Uchino, T, 2009
)
0.68
"Pretreatment with capsazepine, an inhibitor of vanilloid receptor-1 activation, and with KT5720, an inhibitor of protein kinase A, reversed GG-induced increases in CGRP release from DRG neurons."( Effects of topical application of alpha-D-glucosylglycerol on dermal levels of insulin-like growth factor-i in mice and on facial skin elasticity in humans.
Harada, N; Kurihara, H; Nakagata, N; Okajima, K; Zhao, J, 2010
)
0.68
"Pretreatment with capsazepine, a TRPV1 antagonist, significantly decreased capsaicin-evoked EMG activity in both streptozotocin-treated and control rats."( Diabetic rats show reduced cardiac-somatic reflex evoked by intrapericardial capsaicin.
Du, JQ; Foreman, RD; Li, Q; Liu, XH; Qin, C; Sun, N; Tang, JS; Xu, Y, 2011
)
0.69
"Pre-treatment with capsazepine (20 microg, i.a.), a selective VR1 antagonist, inhibited the capsaicin-evoked response, but not that of propofol."( Characteristics of propofol-evoked vascular pain in anaesthetized rats.
Ando, R; Watanabe, C, 2005
)
0.65
"Pretreatment with capsazepine (20 mg/kg i.p.) prevented the reversal of MK-801-induced disruption of PPI by cannabidiol, providing preliminary evidence that TRPV1 receptors are involved in the reversal of MK-801-induced sensorimotor gating deficits by cannabidiol."( Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice.
Long, LE; Malone, DT; Taylor, DA, 2006
)
0.66
"Pre-treatment with capsazepine (30 mg/kg, i.p.) blocked the hypothermia caused by 10 and 20 mg/kg of AM 404."( Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats.
Cowan, A; Ding, Z; Rawls, SM, 2006
)
0.65
"Pretreatment with capsazepine before capsaicin administration also significantly inhibited capsaicin-induced intestinal inflammation."( The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats.
McVey, DC; Vigna, SR, 2001
)
0.63

Toxicity

ExcerptReferenceRelevance
" Toxic effects were assessed by incorporation of [3H]L-leucine into cellular proteins in the presence of capsazepine, the VR1 vanilloid receptor antagonist and Ruthenium red or tyrosine or calcium."( Cytotoxicity of capsaicin in monkey kidney cells: lack of antagonistic effects of capsazepine and Ruthenium red.
Carratú, MR; Cochereau, C; Creppy, EE; Cuomo, V; Ennamany, R; Richeux, F; Saboureau, D, 2000
)
0.75

Bioavailability

ExcerptReferenceRelevance
" These data suggest that an orally bioavailable capsaicin analogue, civamide, possessed analgesic activity with respect to several noxious stimuli, including inflammation-induced hyperalgesia, noxious thermal stimulation and nerve injury-induced tactile allodynia."( Antinociception induced by civamide, an orally active capsaicin analogue.
Chen, P; Hua, XY; Hwang, J; Yaksh, TL, 1997
)
0.3
" In this report, we describe the synthesis and structure-activity relationship of a series of N-aryl cinnamides, the most potent of which (49a and 49b) exhibit good oral bioavailability in rats (F(oral) = 39% and 17%, respectively)."( Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.
Bo, Y; Chakrabarti, PP; Chen, N; Doherty, EM; Fotsch, C; Gavva, N; Han, N; Kelly, MG; Kincaid, J; Klionsky, L; Liu, Q; Norman, MH; Ognyanov, VI; Tamir, R; Treanor, JJ; Wang, X; Zhu, J, 2005
)
0.33
" Exploration of the structure-activity relationships by parallel synthesis identified the essential pharmacophoric elements for antagonism that permitted further optimization via targeted synthesis to provide a potent orally bioavailable and selective TRPV1 modulator 41 active in several in vivo models."( Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
Bogenstaetter, M; Breitenbucher, JG; Carruthers, NI; Chang, L; Chaplan, SR; Codd, EE; Dax, SL; Dubin, AE; Gonzales, L; Hoey, K; Jetter, M; Lee, DH; Liu, C; Lord, B; Mazur, C; Nasser, N; Rizzolio, M; Shah, C; Swanson, DM; Zhang, SP, 2005
)
0.33
"3 min and a high clearance, suggesting that drug bioavailability is considerably reduced following extravascular administrations, consequently affecting drug response."( Characterization of in vitro metabolism of capsazepine, a vanilloid transient receptor potential channel antagonist, by liquid chromatography quadrupole ion trap mass spectrometry.
Beaudry, F; Douat, J; Vachon, P, 2011
)
0.63

Dosage Studied

ExcerptRelevanceReference
") shifted these dose-response curves in parallel to the right."( The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol.
Ohkubo, T; Shibata, M, 1997
)
0.57
" Trypsin also produced a vasodilator dose-response curve that was biphasic in nature (ED(50-1)=0."( Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers.
Ahluwalia, A; Aston, D; McLean, PG; Sarkar, D, 2002
)
0.31
" Dose-response analysis of the antagonistic effect of the TRPV1 receptor antagonist, capsazepine administered peripherally, shows that the capsaicin-evoked inflammation was inhibited in a dose-dependent manner, and nearly completely abolished by capsazepine at doses between 30-150 mug."( Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin.
Fang, L; Li, D; Lin, Q; Xu, X; Zou, X, 2007
)
0.56
" Intra-cerebral administration of cannabidiol, a phytocannabinoid, or anandamide, an endocannabinoid, into the dorsolateral portion of periaqueductal gray (dlPAG) promotes anxiolytic-like effects in several animal models of anxiety with bell-shaped dose-response curves."( Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
Campos, AC; Guimarães, FS, 2009
)
0.35
"9nM) showed a good pharmacokinetic profile upon oral dosing at 10mg/kg in Sprague-Dawley (SD) rats."( Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
Bhosale, VM; Chaudhari, SS; Gudi, GS; Kadam, AB; Karnik, PV; Khairatkar-Joshi, N; Mukhopadhyay, I; Raghuram, A; Rao, SS; Sangana, RR; Thomas, A; Vaiyapuri, TS; Wale, DP, 2013
)
0.39
" The higher doses of capsaicin administered into the vMPFC after the ineffective dose of 6-IODO displaced the dose-response curve of the baroreflex parameters to the right, with no alteration in the maximum effect of capsaicin."( Medial prefrontal cortex TRPV1 channels modulate the baroreflex cardiac activity in rats.
Ferreira-Junior, NC; Lagatta, DC; Resstel, LB, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
capsaicin receptor antagonistAny substance which blocks the painful sensation of heat caused by capsaicin acting on the TRPV1 ion channel.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
catecholsAny compound containing an o-diphenol component.
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
benzazepineA group of two-ring heterocyclic compounds consisting of a benzene ring fused to an azepine ring.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (81)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency39.81070.003245.467312,589.2998AID2517
Chain A, Beta-lactamaseEscherichia coli K-12Potency8.91250.044717.8581100.0000AID485294
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency25.05940.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency6.02160.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency6.02160.025120.237639.8107AID886; AID893
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency44.66840.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency33.99720.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency28.18385.623417.292931.6228AID2323
endonuclease IVEscherichia coliPotency25.11890.707912.432431.6228AID1708
thioredoxin reductaseRattus norvegicus (Norway rat)Potency51.05140.100020.879379.4328AID488773; AID588453
15-lipoxygenase, partialHomo sapiens (human)Potency2.51190.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency50.45130.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency26.60860.004110.890331.5287AID493107; AID504466
USP1 protein, partialHomo sapiens (human)Potency44.66840.031637.5844354.8130AID504865
NFKB1 protein, partialHomo sapiens (human)Potency3.98110.02827.055915.8489AID895; AID928
GLS proteinHomo sapiens (human)Potency18.86000.35487.935539.8107AID624146; AID624170
TDP1 proteinHomo sapiens (human)Potency8.10690.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.75030.180013.557439.8107AID1460
ThrombopoietinHomo sapiens (human)Potency10.00000.02517.304831.6228AID917; AID918
thioredoxin glutathione reductaseSchistosoma mansoniPotency44.66840.100022.9075100.0000AID485364
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency17.21680.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency5.01190.00137.762544.6684AID914; AID915
thyroid stimulating hormone receptorHomo sapiens (human)Potency25.78770.001318.074339.8107AID926; AID938
hypothetical protein, conservedTrypanosoma bruceiPotency24.47020.223911.245135.4813AID624147; AID624173
regulator of G-protein signaling 4Homo sapiens (human)Potency16.83360.531815.435837.6858AID504845
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency19.68300.001530.607315,848.9004AID1224819; AID1224820; AID1224821
67.9K proteinVaccinia virusPotency37.61880.00018.4406100.0000AID720579; AID720580
ParkinHomo sapiens (human)Potency20.59620.819914.830644.6684AID720572
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency44.66840.707936.904389.1251AID504333
arylsulfatase AHomo sapiens (human)Potency0.00541.069113.955137.9330AID720538
IDH1Homo sapiens (human)Potency31.62280.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency8.85170.035520.977089.1251AID504332; AID588346
Bloom syndrome protein isoform 1Homo sapiens (human)Potency19.95260.540617.639296.1227AID2364; AID2528
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency22.10610.00207.533739.8107AID891
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency12.58931.000012.232631.6228AID1452
cytochrome P450 2C19 precursorHomo sapiens (human)Potency2.66400.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency6.99060.00636.904339.8107AID883
D(1A) dopamine receptorHomo sapiens (human)Potency1.11320.02245.944922.3872AID488982; AID488983
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency19.62210.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency47.39350.006026.168889.1251AID488953; AID540317
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency11.22020.01789.637444.6684AID588834
DNA polymerase betaHomo sapiens (human)Potency28.18380.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency31.62280.039816.784239.8107AID995
flap endonuclease 1Homo sapiens (human)Potency141.25400.133725.412989.1251AID588795
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency0.89130.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency0.89130.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency0.89130.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency28.18380.00798.23321,122.0200AID2546
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency39.81070.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency4.51410.004611.374133.4983AID463097; AID504364; AID624297
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.16230.031610.279239.8107AID884; AID885
M-phase phosphoprotein 8Homo sapiens (human)Potency39.81070.177824.735279.4328AID488949
lethal factor (plasmid)Bacillus anthracis str. A2012Potency14.21910.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency9.14980.891312.067628.1838AID1459; AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency10.00000.015812.3113615.5000AID1461
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency12.58930.316212.765731.6228AID881
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency8.39020.00638.235039.8107AID881; AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
TAR DNA-binding protein 43Homo sapiens (human)Potency5.62341.778316.208135.4813AID652104
GABA theta subunitRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency10.85980.060110.745337.9330AID485367; AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)IC50 (µMol)114.45280.00040.21474.0000AID179770; AID181375; AID218299; AID218303; AID218485; AID242298; AID242473; AID313132; AID313133; AID313136; AID313137
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)Ki0.94000.00010.64456.4000AID1797967; AID1797968; AID218321; AID218324; AID238266; AID238267; AID238617; AID238618; AID305010; AID305011; AID312166; AID312169
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)IC50 (µMol)18.00000.02001.27553.9000AID779486
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)0.25870.00020.606010.0000AID1066646; AID1177525; AID218474; AID218476; AID242337; AID242558; AID242777; AID242788; AID248829; AID257670; AID313130; AID313131; AID313134; AID313135; AID779485
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)Ki0.50930.00010.67956.4000AID1797976; AID218481; AID218483
Transient receptor potential cation channel subfamily M member 8Mus musculus (house mouse)IC50 (µMol)50.00000.40003.06679.0000AID1177522; AID1177523
Transient receptor potential cation channel subfamily V member 4Rattus norvegicus (Norway rat)IC50 (µMol)162.97500.03701.45415.9000AID179770; AID181375; AID218299; AID218303
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)IC50 (µMol)162.97500.03701.93458.6000AID179770; AID181375; AID218299; AID218303
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.00050.43182.3800AID175322
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)1.27190.00051.06746.3096AID1797977; AID478382
Transient receptor potential cation channel subfamily V member 4Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.03000.33150.9000AID175322
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.03000.45071.7000AID175322
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (78)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
ligand-gated calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (22)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
endoplasmic reticulum membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
membrane raftTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (151)

Assay IDTitleYearJournalArticle
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347152Confirmatory screen NINDS AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347167Vero cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347168HepG2 cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347153Confirmatory screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346617Human TRPV1 (Transient Receptor Potential channels)2001British journal of pharmacology, Mar, Volume: 132, Issue:5
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1).
AID1346643Rat TRPV1 (Transient Receptor Potential channels)2001British journal of pharmacology, Mar, Volume: 132, Issue:5
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID779493Inhibition of acetone spray-induced cold allodynia in Sprague-Dawley rat chronic constriction injury model at 10 mg/kg, ip after 0.5 hrs2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID242337Inhibition of human transient receptor potential vanilloid 1 receptor (n=5)2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
AID242558In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assay2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
AID1177522Antagonist activity against mouse TRPM8 expressed in T-REx HEK cells assessed as inhibition of menthol-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to menthol stimulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID1066644Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of icilin-induced intracellular Ca2+ influx by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID386035Reduction of capsaocin-induction of allodynia in Swiss mouse2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID305012Agonist activity at rat TRPV1 expressed in CHO cells assessed as maximal calcium uptake2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.
AID246722Induction of [Ca2+] uptake in CHO cells expressing rat TRPV1 at 10-30 uM relative to 300 nM capsaicin; Not effective2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
AID238266Antagonist activity for rat TRPV1 expressed in CHO cells2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
AID242777In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assay2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
AID1066645Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of menthol-induced intracellular Ca2+ influx by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID312166Displacement of [3H]RTX from rat TRPV1 receptor expressed in CHO cells2008Journal of medicinal chemistry, Jan-10, Volume: 51, Issue:1
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
AID1066646Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of CAP-induced intracellular Ca2+ influx by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID1177517Agonist activity at mouse TRPM8 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay relative to ionomycin2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID524791Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID257670Inhibition of calcium influx evoked by capsaicin in human TRPV1 expressing cells by fluorescence assay2006Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID175840In vitro agonist activity against [Ca2+] uptake in neonatal rat cultured spinal sensory neurons1994Journal of medicinal chemistry, Jun-24, Volume: 37, Issue:13
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.
AID312167Agonist activity at rat TRPV1 receptor expressed in CHO cells assessed as calcium 45 uptake at 30 uM2008Journal of medicinal chemistry, Jan-10, Volume: 51, Issue:1
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
AID238618In vitro inhibition of [3H]RTX binding to rat TRPV1 expressed in CHO cells2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
AID218321Inhibition of capsaicin-induced [Ca2+] uptake by Rat Vanilloid receptor 1 (VR1) expressing CHO cells2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
AID1177519Agonist activity at human TRPV1 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay relative to ionomycin2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID313127Reversal of mechanical hyperalgesia in guinea pig partial sciatic nerve ligation-induced neuropathic pain model at 1 to 30 mg/kg, sc2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID218164In vitro agonist activity at the vanilloid receptor in rat DRG neurons; Not effective at 30 uM.2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity.
AID1177521Agonist activity at human TRPA1 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay relative to ionomycin2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID175328Agonist activity tested in [Ca2+] -influx assay by using neonatal rat cultured spinal sensory neurons2003Bioorganic & medicinal chemistry letters, Jan-20, Volume: 13, Issue:2
Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptor.
AID1177518Agonist activity at human TRPV1 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID180309Inhibition of [Ca2+] uptake in dorsal root ganglion (DRG) neurons from neonatal Sprague-Dawley rat2003Bioorganic & medicinal chemistry letters, Dec-15, Volume: 13, Issue:24
Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects.
AID524796Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID180308Inhibitory concentration of compound against 45 [Ca2+] influx in neonatal rat cultured spinal sensory neurons2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists.
AID1177524Antagonist activity against mouse TRPM8 expressed in T-REx HEK cells assessed as inhibition of cold-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to cold stimulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID1066637Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of cold-induced intracellular Ca2+ influx by Fluo-8 AM staining-based fluorescence analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID386032Activity at TRPA1 channel in rat dorsal root ganglion neurons assessed as attenuation of capsaicin-induced intracellular calcium2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID386033Attenuation of capsaicin-induction of paw lifting in Swiss mouse2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID210793Antagonistic activity against human transient receptor potential vanilloid type 1 in FLIPR assay2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Discovery of small molecule antagonists of TRPV1.
AID305011Antagonist activity at rat TRPV1 expressed in CHO cells assessed as inhibition of calcium uptake2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.
AID179770In vitro inhibitory concentration was determined against [45Ca2+]- influx in rat DRG neurons2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.
AID242298Inhibition of rat transient receptor potential vanilloid 1 receptor (n=2)2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
AID313135Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by [45Ca2+] uptake assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID1177523Antagonist activity against mouse TRPM8 expressed in T-REx HEK cells assessed as inhibition of icilin-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to icilin stimulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID1177520Agonist activity at human TRPA1 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID218485Vanilloid receptor subtype 1 antagonist activity based on its ability to block capsaicin-induced (CAP) activation of the rat VR1 channel in a HEK293 cell line2003Bioorganic & medicinal chemistry letters, Oct-20, Volume: 13, Issue:20
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonists.
AID218324In vitro binding affinity towards Rat Vanilloid receptor 1 (VR1) by [3H]RTX displacement.2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
AID313134Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by [45Ca2+] uptake assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID246449Agonist activity by [Ca2+] uptake in CHO cells expressing rat TRPV1 at 10-30 uM; NE = Not effective2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
AID1066628Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of proton-induced intracellular Ca2+ influx at 10 uM by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID313133Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by aequorin based assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID77516Reduced hyperalgesia by Freunds complete adjuvant (FCAT) in guinea pig at 1-30 mg/kg subcutaneous dose2004Journal of medicinal chemistry, May-20, Volume: 47, Issue:11
Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?
AID313132Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by aequorin based assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID218476Functional antagonistic activity against human vanilloid receptor subtype 1 in HEK293 cell membranes was determined as inhibition of agonist-induced increases in intracellular [Ca2+] levels2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1.
AID1574435Antiproliferative activity against human HeLa cells after 24 hrs by cell titer 96 aqueous non-radioactive cell proliferation assay2019Bioorganic & medicinal chemistry, 01-01, Volume: 27, Issue:1
Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types.
AID1066654Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of heat-induced intracellular Ca2+ influx measured for 42 mins by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID779492Inhibition of acetone spray-induced cold allodynia in Sprague-Dawley rat chronic constriction injury model at 10 mg/kg, ip after 1 hr2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID779485Inhibition of TRPV1 (unknown origin)2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID175670Effective concentration of compound to induce 45 [Ca2+] influx in neonatal rat cultured spinal sensory neurons2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists.
AID312169Antagonist activity at rat TRPV1 receptor expressed in CHO cells assessed as calcium 45 uptake2008Journal of medicinal chemistry, Jan-10, Volume: 51, Issue:1
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
AID313131Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by aequorin based assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID218327In vitro [Ca2+] influx relative to capsaicin by Rat Vanilloid receptor (VR1) expressing CHO cells (ineffective)2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
AID242473In vitro inhibition of acid activated rat TRPV1 receptor in [Ca2+] influx assay2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
AID181520Antagonist activity tested in [Ca2+] -influx assay by using neonatal rat cultured spinal sensory neurons2003Bioorganic & medicinal chemistry letters, Jan-20, Volume: 13, Issue:2
Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptor.
AID779491Inhibition of acetone spray-induced cold allodynia in Sprague-Dawley rat chronic constriction injury model at 10 mg/kg, ip after 2 hrs2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID524792Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID478382Antagonist activity at human TRPV1 expressed in tetracycline-stimulated HEK293 cells assessed as inhibition of capsaicin-induced intracellular calcium levels by fluorimetric assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
In vitro TRPV1 activity of piperine derived amides.
AID305010Displacement of [3H]RTX from rat TRPV1 expressed in CHO cells2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.
AID218481Binding affinity towards cloned human vanilloid receptor subtype 1 in HEK293 cell membranes using [3H]RTX as radioligand2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1.
AID313130Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by aequorin based assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID1066641Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of icilin-induced intracellular Ca2+ influx at >50 uM by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID478383Antagonist activity at human TRPV1 expressed in tetracycline-stimulated HEK293 cells assessed as inhibition of capsaicin-induced intracellular calcium levels by fluorimetric assay relative to control2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
In vitro TRPV1 activity of piperine derived amides.
AID524794Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID168446Increased latency in paw-withdrawal response in rat on intradermal injection2004Journal of medicinal chemistry, May-20, Volume: 47, Issue:11
Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?
AID179578In vitro antagonist activity against [Ca2+] uptake in neonatal rat cultured spinal sensory neurons1994Journal of medicinal chemistry, Jun-24, Volume: 37, Issue:13
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.
AID248829Inhibition of capsaicin-induced calcium uptake by transient receptor potential vanilloid type 1 expressed in CHO cells2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.
AID1177527Non-specific effect on intracellular Ca2+ accumulation in T-REx HEK cells at >50 uM2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID175322Ability to cause [Ca2+] influx in neonatal rat cultured spinal sensory neurons.2003Bioorganic & medicinal chemistry letters, May-05, Volume: 13, Issue:9
Chain-branched acyclic phenethylthiocarbamates as vanilloid receptor antagonists.
AID238267Antagonist activity towards rat TRPV1 expressed in CHO cells2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
AID313129Reversal of carrageenan-induced thermal hyperalgesia in guinea pig inflammatory pain model at 30 mg/kg, sc2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID316416Bronchodilation activity against leukotriene D4-induced constriction in human lung small airways assessed as remaining contraction at 10 uM after 1.5 hrs relative to control2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure.
AID218483Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.
AID313136Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by [45Ca2+] uptake assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID1066653Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of proton-induced intracellular Ca2+ influx at 100 uM by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID181375Ability to inhibit [Ca2+] influx neonatal rat cultured spinal sensory neurons.2003Bioorganic & medicinal chemistry letters, May-05, Volume: 13, Issue:9
Chain-branched acyclic phenethylthiocarbamates as vanilloid receptor antagonists.
AID218474Antagonistic activity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane, as inhibition of agonist-induced intracellular [Ca2+] levels.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.
AID524793Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID524795Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1177516Agonist activity at mouse TRPM8 expressed in T-REx HEK cells assessed as increase in intracellular Ca2+ accumulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID238617In vitro binding affinity for rat TRPV1 expressed in CHO cells using [3H]-RTX2005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
AID218303In vitro antagonist activity at the vanilloid receptor in rat DRG neurons.2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity.
AID313128Reversal of hyperalgesia in guinea pig Freund's adjuvant-induced inflammatory pain model at 3 to 30 mg/kg, sc2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID226640Effect on cooperativity of Resiniferatoxin (RTX) binding (Hill coefficient)1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilloid (capsaicin) receptor with different degrees of cooperativity.
AID1177526Antagonist activity against human TRPA1 expressed in T-REx HEK cells assessed as inhibition of AITC-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to AITC stimulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID313137Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by [45Ca2+] uptake assay2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
AID218309Displacement of [3H]RTX from Vanilloid receptor in Rat spinal cord membranes1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilloid (capsaicin) receptor with different degrees of cooperativity.
AID218299Antagonistic activity against vanilloid receptor as concentration to reduce the response to 0.5 mM capsaicin by 50% from neonatal rat culture spinal sensory neurons using [Ca2+] -influx assay2003Bioorganic & medicinal chemistry letters, Feb-24, Volume: 13, Issue:4
Synthesis of N,N',N"-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor.
AID242788Inhibition of 100 nM capsaicin effect on intracellular [Ca2+] concentration in HEK293 cells expressing human TRPV12005Journal of medicinal chemistry, Jul-14, Volume: 48, Issue:14
The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination.
AID218461Antagonistic activity against vanilloid receptor 1 (TRPV1)2004Journal of medicinal chemistry, May-20, Volume: 47, Issue:11
Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?
AID524790Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1177525Antagonist activity against human TRPV1 expressed in T-REx HEK cells assessed as inhibition of capsaicin-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to capsaicin stimulation by Fluo-4 AM dye based fluorescence assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
AID779490Inhibition of acetone spray-induced cold allodynia in Sprague-Dawley rat chronic constriction injury model at 10 mg/kg, ip after 3 hrs2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID779486Inhibition of TRPM8 (unknown origin)2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1797967Competition Binding Assay and Inhibition of Ca2+ Uptake Assay from Article 10.1021/jm701049p: \\Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-Benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.\\2008Journal of medicinal chemistry, Jan-10, Volume: 51, Issue:1
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
AID1797976Radioligand Binding Assay and Antagonist Ca2+ Influx Functional Assay from Article 10.1124/jpet.107.124305: \\[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand2007The Journal of pharmacology and experimental therapeutics, Oct, Volume: 323, Issue:1
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
AID1797977FLIPR (Fluorescence Imaging Plate Reader)-Based Ca2+ Assay from Article 10.1016/j.bmcl.2004.05.028: \\Discovery of small molecule antagonists of TRPV1.\\2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Discovery of small molecule antagonists of TRPV1.
AID1797968Competition Binding Assay and Inhibition of Ca2+ Uptake Assay from Article 10.1016/j.bmc.2007.06.041: \\Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.\\2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.
AID493017Wombat Data for BeliefDocking2004Bioorganic & medicinal chemistry, Jan-15, Volume: 12, Issue:2
N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region".
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (772)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's80 (10.36)18.2507
2000's376 (48.70)29.6817
2010's278 (36.01)24.3611
2020's38 (4.92)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.01 (24.57)
Research Supply Index6.67 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.38%)5.53%
Reviews9 (1.15%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other769 (98.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]